Does ANAKINRA Cause Diffuse large b-cell lymphoma? 46 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Diffuse large b-cell lymphoma have been filed in association with ANAKINRA (Kineret). This represents 0.4% of all adverse event reports for ANAKINRA.
46
Reports of Diffuse large b-cell lymphoma with ANAKINRA
0.4%
of all ANAKINRA reports
14
Deaths
31
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From ANAKINRA?
Of the 46 reports, 14 (30.4%) resulted in death, 31 (67.4%) required hospitalization, and 11 (23.9%) were considered life-threatening.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANAKINRA. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does ANAKINRA Cause?
Off label use (4,317)
Drug ineffective (3,368)
Pain (1,344)
Condition aggravated (1,339)
Rheumatoid arthritis (1,300)
Drug intolerance (946)
Joint swelling (921)
Injection site pain (879)
Product dose omission issue (864)
Arthralgia (850)
What Other Drugs Cause Diffuse large b-cell lymphoma?
RITUXIMAB (1,571)
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
Which ANAKINRA Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
ANAKINRA vs ANAMORELIN
ANAKINRA vs ANASTROZOLE
ANAKINRA vs ANDEXANET ALFA
ANAKINRA vs ANDROGEL
ANAKINRA vs ANETHOLTRITHION